The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...
Investigators sought to determine whether abemaciclib plus letrozole showed clinically meaningful activity in patients with advanced or recurrent endometrioid endometrial cancer.